Early diagnosis of Wild-type Transthyretin Amyloidosis Cardiomyopathy by optimized screening of patients undergoing Carpal Tunnel Syndrome Surgery (CACTuS II)

30 August 2025 (08:15 - 09:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mrs Sie Kronborg Fensman

Aarhus University Hospital, Aarhus N (Denmark)

5 More presentations in this session

Presentation thumbnail

Empagliflozin versus dapagliflozin in heart failure

Mr K. Bonnesen (Copenhagen, DK)

Abstract Slides Video

Presentation thumbnail

Home-based rehabilitation in patients with chronic heart failure after acute decompensation: primary results of the PILOT-CRHF trial

Doctor A. Reuser (Leipzig, DE)

Abstract Slides Video

Presentation thumbnail

Efficacy of early angiotensin receptor/neprilysin inhibition in post-myocardial infarction patients: a meta-analysis of randomized controlled trials

Associate Professor C. Hsu (Taipei, TW)

Abstract Slides Video

Presentation thumbnail

Remote rapid titration of heart failure therapies

Doctor A. Abdel-Gadir (London, GB)

Abstract Slides Video

Presentation thumbnail

Short- and long-term effects of empagliflozin on sodium balance and fluid regulation in chronic heart failure

Doctor V. Bytyqi (Erlangen, DE)

Abstract Slides Video

Access the full session

Session thumbnail

Heart failure therapy across the spectrum

The Event

Event poster

ESC Congress 2025

30 August 2025 08:15 CET

You may be interested in

Congress Presentation

Characterization of patients with cardiac amyloidosis diagnosed at the time of idiopathic carpal tunnel surgery

Congress Presentation

Screening cardiac amyloidosis in carpal tunnel syndrome patients: is it worth it?

Congress Presentation

Diagnostic, therapeutic and prognostic implications of carpal tunnel syndrome and spinal stenosis in wild-type transthyretin cardiac amyloidosis.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources